Ulrike Schara

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

Journal: Journal of neuromuscular diseases

Published: August 27, 2026

Clinical, histopathological, and biomarker characterization of XLMTM and ADCNM: Operational lessons, screening and baseline data of the Unite-CNM study.

Clinical, histopathological, and biomarker characterization of XLMTM and ADCNM: Operational lessons, screening and baseline data of the Unite-CNM study.

Journal: Journal of neuromuscular diseases

Published: August 14, 2026

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Journal: The Lancet regional health. Europe

Published: June 28, 2024

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.

Journal: Journal of neuromuscular diseases

Published: December 04, 2022

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.

Journal: Journal of neurology

Published: July 27, 2022

Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?

Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?

Journal: Journal of neuromuscular diseases

Published: April 18, 2022

Patterns of cardiac involvement in different muscular dystrophies assessed by magnetic resonance imaging.

Patterns of cardiac involvement in different muscular dystrophies assessed by magnetic resonance imaging.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: February 11, 2022

1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy.

1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy.

Journal: Orphanet journal of rare diseases

Published: July 26, 2021

NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.

NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.

Journal: Brain : a journal of neurology

Published: July 20, 2021

Erratum to "Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?"

Erratum to "Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?"

Journal: Journal of neuromuscular diseases

Published: February 13, 2021

Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.

Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.

Journal: Nature medicine

Published: January 28, 2021

International retrospective natural history study of LMNA-related congenital muscular dystrophy.

International retrospective natural history study of LMNA-related congenital muscular dystrophy.

Journal: Brain communications

Published: December 23, 2020

Showing 1-12 of 102

Last Updated: 09/26/2026